COMP <GO>
BCYC vs AMRN // 10Y YIELD & FRED MACRO BETA
Bicycle Therapeutics plc (NASDAQ) VS. Amarin Corporation plc (NASDAQ) • 15-METRIC TALLY: BCYC 3
— AMRN 4
■ METRIC PARITY
LAST: $3.82 (-1.55%) • MKT CAP: $267.4M
macro-sensitivity
—
LAST: $12.74 (-0.08%) • MKT CAP: $262.8M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BCYC VS. AMRN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BCYC | AMRN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 56.60% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -12.20% | -22.80 | AMRN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 2.56% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -23.50% | -36.50 | AMRN | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -18.20% | -41.80 | AMRN | /net-margins <GO> |
| Revenue Growth (YoY) | 105.80% | -6.50% | +112.30 | BCYC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 6/9 | -4.00 | AMRN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.1 | 46.6 | +1.42 | BCYC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $267.4M | $262.8M | $4.6M | BCYC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BCYC REV | AMRN REV | BCYC GROSS % | AMRN GROSS % | BCYC FCF | AMRN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $72.6M | $213.6M | — | 56.6% | -$252.0M | $6.7M |
| FY 2024 | $35.3M | $228.6M | — | 35.6% | -$166.0M | -$31.0M |
| FY 2023 | $27.0M | $306.9M | — | — | -$60.6M | $6.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BCYC // BETA —
AMRN // BETA —